The high levels of ROS in krit1 knock-out (KRIT1-KO) cells, derived from a murine model of the human CCM pathology, makes them an optimal cellular tool [75] to test the properties of PdNPs as antioxidant nanozymes. The gene discussed is KRIT1; the disease is cerebral cavernous malformation.